In January, pharmacists will be given access to publicly funded diphtheria-tetanus-acellular pertussis combined vaccine (dTap) to vaccinate pregnant women. This session will help you to understand diphtheria, tetanus and pertussis and the relevant recommendations for dTap vaccination in pregnancy.
In January, pharmacists will be given access to publicly funded pneumococcal vaccine to vaccinate people 65 years of age and older. This session will help you to understand pneumococcal disease and relevant recommendations for pneumococcal vaccination.
This harm reduction focused program, presented jointly by RxA and ACP, is aimed at helping pharmacists learn about collaboration strategies to assist in the building and maintenance of professional relationships with patients requiring harm reduction measures and how to foster interdisciplinary collaboration.